Infinium Pharmachem IPO: For the purpose of producing and supplying different pharmaceutically related chemicals, bulk medications, pharmaceutical intermediates, etc., Infinium Pharmachem was established. In light of this, the Company’s business is focused on producing and supplying iodine derivatives, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs).
Infinium Pharmachem IPO Dates
The Infinium Pharmachem IPO is scheduled to begin on March 31, 2023. The deadline for subscriptions is 5 April 2023. The IPO’s size is 25.31 crores rupees. The value of the shares issued under the fresh issue mode is Rs. 25.31 crore. There are no shares issued via an offer for sale. There are 1000 shares in the lot, and each share costs 135 rupees. The business will list on the NSE SME. This Fixed Price issuance has a face value of Rs. 10 per share. Bigshare Services Private Ltd is the firm’s registrar.
Infinium Pharmachem IPO Details
| IPO OPENING DATE | 31 March., 2023 |
| CLOSING DATE FOR IPO | 5 April, 2023 |
| ISSUE TYPE | Fixed Price Issue |
| Face Value per share | 10 Rs. per share |
| IPO price band | 135 Rs per share |
| LOT SIZE | 1000 shares |
| MINIMUM ORDER QUANTITY | 1000 shares |
| ISSUE SIZE | 25.31 Crore Rs. |
| OFFER FOR SALE | No shares are issued through offer-for-sale mode. |
| FRESH ISSUE | 25.31 Crore Rs. |
| LISTING AT | NSE SME |
| LISTING DATE | 17 April, 2023 |
Important Dates of Infinium Pharmachem IPO
The subscription period for the Infinium Pharmachem IPO starts on March 31, 2023. The period for IPO subscription would end on 5 April 2023. On April 11, 2023, the stockholders who applied will learn their allocation status. Refunds for those who did not receive an allocation would start on April 12, 2023. On April 13, 2023, credits to shareholders’ DEMAT accounts would be made. On April 17, 2023, the company’s listing would be accompanied.
| IPO OPENING DATE | 31 March 2023 |
| CLOSING DATE FOR IPO | 5 April 2023 |
| IPO ALLOTMENT DATE | 11 April 2023 |
| REFUNDS | 12 April 2023 |
| DEMAT A/C CREDITED ON | 13 April 2023 |
| IPO LISTING DATE | 17 April 2023 |
Infinium Pharmachem IPO Lot Size
The Infinium Pharmachem IPO lot size is 1000 shares.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1000 | ₹135,000 |
| Retail (Max) | 1 | 1000 | ₹135,000 |
| HNI (Min) | 2 | 2,000 | ₹270,000 |
Infinium Pharmachem IPO Promoter Holding
Mr. Sanjaykumar Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani, and Mr. Mitesh Lavjibhai Chikhaliya are the company promoters.
Objects of the Infinium Pharmachem IPO
- IPO proceeds would be used for general corporate purposes.
- The company needs the IPO money for expansion plans.
- The money will be utilised for fulfilling the marketing requirements of the company.
- For payment of the outstanding loans and borrowings,
About Infinium Pharmachem IPO
The IPO for Infinium Pharmachem will begin trading on March 31, 2023. The business produces large amounts of APIs, iodine derivatives, and pharmaceuticals based on iodination reactions. Infinium Pharmachem started running its business in 2003. Additionally, it has a staff for internal research and development.
Infinium Pharmachem conducts business with a variety of sectors, including those linked to nutraceuticals, pharmaceuticals, agrichemicals, specialty chemicals, and other chemicals. Gujarat is home to its production facility. The size of Infinium Pharmachem is 4100 square feet. With more than 200 Iodine Derivatives and more than 7 APIs, it conducts business in 15 different countries.
With the help of the CRAMS Model, or Contract Research & Manufacturing Services, the company entered the pharmaceutical sector.
The Company’s manufacturing capabilities and technical know-how today successfully serve a wide range of industries, including pharmaceutical and biotech, specialty and performance chemicals, agrochemicals, human and animal health, cosmetics, sanitation, electrical, electronics, and much more.
With all of its clients, including pharmaceutical, biotech, and fine chemical industries, the company has established and maintained long-term healthy partnerships. Its goods are sold to more than 250 clients worldwide. In 2019, Shanghai Tajilin Industrial Co. Ltd., a joint venture (JV) between the Company and Shanghai Witofly Chemical Co. Ltd., was established in the People’s Republic of China.